457 Objectives: Increased angiogenesis is a marker of aggressiveness in many cancers.
Targeted radionuclide therapy of these cancers with angiogenesis-targeting agents may …

Purpose Increased angiogenesis is a marker of aggressiveness in many cancers. Targeted
radionuclide therapy of these cancers with angiogenesis-targeting agents may curtail this …

In this study, we carried out a radioimmunoconjugation using 177Lu with anti-CD105
(endoglin) monoclonal antibody for an angiogenesis targeting. CD105 has been shown to …

Currently, great interest is focused on angiogenesis and on its potential clinical implications
in cancer. An intriguing approach relies on the selective targeting of the surface molecules …

539 Objectives: Angiogenesis is one of the hallmarks of cancer, enabling increased tumor
growth and metastasis. Therefore, imaging of angiogenesis may enable sensitive detection …

Currently, great interest is focused on angiogenesis and on its potential clinical implications
in cancer. An intriguing approach relies on the selective targeting of the surface molecules …

232 Objectives Angiogenesis is an indispensable process during tumor development.
Microvessel density (MVD) assessment based on CD105 staining is an independent …

395 Objectives To generate and characterize the Fab fragment of TRC105, a monoclonal
antibody that binds with high affinity to human and murine CD105 (ie endoglin), and …

70 Objectives Overexpression of CD105 (ie endoglin) correlates with poor prognosis in> 10
solid tumor types. Tumor microvessel density assessed by CD105 staining is the current …

1490 Objectives: High syndecan-1 (CD 138) expression proved to be a new independent
prognostic marker for breast carcinoma and was related to an aggressive phenotype and …